JP2023536497A5 - - Google Patents
Info
- Publication number
- JP2023536497A5 JP2023536497A5 JP2023507480A JP2023507480A JP2023536497A5 JP 2023536497 A5 JP2023536497 A5 JP 2023536497A5 JP 2023507480 A JP2023507480 A JP 2023507480A JP 2023507480 A JP2023507480 A JP 2023507480A JP 2023536497 A5 JP2023536497 A5 JP 2023536497A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- antigen peptide
- dementia
- pharmaceutical formulation
- defined above
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20189425.0 | 2020-08-04 | ||
| EP20189425 | 2020-08-04 | ||
| PCT/EP2021/071778 WO2022029181A1 (en) | 2020-08-04 | 2021-08-04 | Immunogenic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536497A JP2023536497A (ja) | 2023-08-25 |
| JP2023536497A5 true JP2023536497A5 (enExample) | 2024-08-13 |
Family
ID=72178339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507480A Pending JP2023536497A (ja) | 2020-08-04 | 2021-08-04 | 免疫原性化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230287050A1 (enExample) |
| EP (1) | EP4192493A1 (enExample) |
| JP (1) | JP2023536497A (enExample) |
| KR (1) | KR20230044524A (enExample) |
| CN (1) | CN116261464A (enExample) |
| AU (1) | AU2021322080A1 (enExample) |
| CA (1) | CA3185563A1 (enExample) |
| IL (1) | IL300364A (enExample) |
| MX (1) | MX2023001483A (enExample) |
| WO (1) | WO2022029181A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240147981A (ko) * | 2022-02-09 | 2024-10-10 | 에이씨 이뮨 에스에이 | 항-알파시누클레인 치료 백신 |
| AU2024211543A1 (en) | 2023-01-26 | 2025-07-17 | Ac Immune Sa | Liposomal construct |
| WO2025109524A1 (en) | 2023-11-22 | 2025-05-30 | Ac Immune Sa | Assays and methods for assessing vaccine preparations |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2361928T3 (pl) | 2003-05-19 | 2017-09-29 | Prothena Biosciences Limited | Skrócone fragmenty alfa-synukleiny w chorobie z ciałami Lewy'ego |
| US20050203010A1 (en) | 2003-11-14 | 2005-09-15 | Atgen Co., Ltd. | Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
| AT506535B1 (de) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
| AT508638B1 (de) | 2009-08-21 | 2011-08-15 | Affiris Ag | Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien |
| SI2723379T1 (sl) * | 2011-06-23 | 2019-03-29 | Biogen International Neuroscience Gmbh | Molekule, ki se vežejo ma anti alfa-sinuklein |
| RU2734924C2 (ru) | 2015-11-03 | 2020-10-26 | Аффирис Аг | Способ вакцинации против аутоантигена у пациента-человека |
| CA3051839A1 (en) | 2017-02-17 | 2018-08-23 | Bristol-Myers Squibb Company | Antibodies to alpha-synuclein and uses thereof |
| EP3638298A4 (en) * | 2017-06-16 | 2021-05-05 | United Neuroscience | PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN-PROTEIN AND FORMULATIONS THEREOF FOR THE TREATMENT OF SYNUCLEINOPATHIA |
| US20230074436A1 (en) * | 2019-09-20 | 2023-03-09 | Denali Therapeutics Inc. | Anti-alpha-synuclein antibodies and methods of use thereof |
-
2021
- 2021-08-04 CA CA3185563A patent/CA3185563A1/en active Pending
- 2021-08-04 KR KR1020237007745A patent/KR20230044524A/ko active Pending
- 2021-08-04 JP JP2023507480A patent/JP2023536497A/ja active Pending
- 2021-08-04 US US18/014,846 patent/US20230287050A1/en active Pending
- 2021-08-04 EP EP21758636.1A patent/EP4192493A1/en active Pending
- 2021-08-04 CN CN202180050068.9A patent/CN116261464A/zh active Pending
- 2021-08-04 MX MX2023001483A patent/MX2023001483A/es unknown
- 2021-08-04 IL IL300364A patent/IL300364A/en unknown
- 2021-08-04 WO PCT/EP2021/071778 patent/WO2022029181A1/en not_active Ceased
- 2021-08-04 AU AU2021322080A patent/AU2021322080A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536497A5 (enExample) | ||
| RU2011100126A (ru) | Применение мимотопов для лечения бетта-амилоидозов | |
| RU2011100125A (ru) | Соединения для лечения амилоидозов | |
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| KR102869640B1 (ko) | 항-aveta 치료적 백신 | |
| JP2022529529A5 (enExample) | ||
| HUE031860T2 (en) | PCSK9 vaccine | |
| HK1249859A1 (zh) | Pcsk9肽疫苗 | |
| TW201345927A (zh) | 組成物 | |
| US20250152684A1 (en) | Anti-Alpha-Synuclein Therapeutic Vaccines | |
| US20230287050A1 (en) | Immunogenic Compounds | |
| JP2025506472A5 (enExample) | ||
| CN104507966B (zh) | 基于补体组分c5a的疫苗 | |
| CN118660717A (zh) | 抗α-突触核蛋白的治疗性疫苗 | |
| EA051687B1 (ru) | Терапевтические вакцины против альфа-синуклеина | |
| JP2012510794A5 (enExample) | ||
| EP2532359A1 (en) | CETP fragments | |
| WO2024156908A1 (en) | Liposomal construct | |
| JP2024538615A5 (enExample) | ||
| TW201348264A (zh) | 組成物 | |
| HK1170248A (en) | Immunogenes peptide |